OptiNose, Inc.·4

Oct 19, 4:03 PM ET

Pickering Larry G 4

4 · OptiNose, Inc. · Filed Oct 19, 2017

Insider Transaction Report

Form 4
Period: 2017-10-17
Transactions
  • Conversion

    Common Stock

    2017-10-17+327,757327,757 total
  • Conversion

    Series C Convertible Preferred Stock

    2017-10-1782,7130 total
    Common Stock (238,866 underlying)
  • Conversion

    Series C-1 Convertible Preferred Stock

    2017-10-1720,7150 total
    Common Stock (59,822 underlying)
  • Conversion

    Series C-2 Convertible Preferred Stock

    2017-10-1710,0660 total
    Common Stock (29,069 underlying)
Footnotes (2)
  • [F1]Represents the total number of shares of Common Stock received by the Reporting Person upon conversion of Series C, Series C-1 and Series C-2 Preferred Stock in connection with the closing of the Issuer's initial public offering.
  • [F2]The Series C, Series C-1, and Series C-2 Preferred Stock converted into Common Stock on a 2.8879-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C, Series C-1 and Series C-2 Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.

Documents

1 file
  • 4
    a4.xmlPrimary

    4